These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10148513)

  • 1. Stroke in the elderly treated for systolic hypertension (SHEP).
    Singer RB
    J Insur Med; 1991; 23(4):265-9. PubMed ID: 10148513
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
    Petrovitch H; Vogt TM; Berge KG
    Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke in the elderly treated for systolic hypertension (SHEP) part II--mortality.
    Singer RB
    J Insur Med; 1992; 24(1):28-31. PubMed ID: 10148474
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
    Probstfield JL; Applegate WB; Borhani NO; Curb JD; Cutler JA; Davis BR; Furberg CD; Hawkins CM; Lakatos E; Page LB
    Clin Exp Hypertens A; 1989; 11(5-6):973-89. PubMed ID: 2676266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments].
    Ménard J; Chatellier G
    Presse Med; 1992 Nov; 21(37):1762-7. PubMed ID: 1362612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic hypertension in older persons.
    Applegate WB
    Adv Intern Med; 1992; 37():37-54. PubMed ID: 1558003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term therapy with atenolol and chlorthalidone in medium- and high-grade arterial hypertension].
    Budriesi N; Adalio G; Zamboni A; Turina MC
    G Clin Med; 1986 Apr; 67(2):109-13. PubMed ID: 3792715
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Davis BR; Vogt T; Frost PH; Burlando A; Cohen J; Wilson A; Brass LM; Frishman W; Price T; Stamler J
    Stroke; 1998 Jul; 29(7):1333-40. PubMed ID: 9660383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
    Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
    JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J; Whelton PK
    J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atenolol-chlorthalidone combination vs placebo: controlled clinical trial in patients with medium-mild arterial hypertension].
    Campana C; Ferrario M; Tondi C; Montemartini C
    Minerva Cardioangiol; 1985 Oct; 33(10):643-7. PubMed ID: 3908972
    [No Abstract]   [Full Text] [Related]  

  • 14. Competing cardiovascular and noncardiovascular risks and longevity in the systolic hypertension in the elderly program.
    Kostis WJ; Cabrera J; Messerli FH; Cheng JQ; Sedjro JE; Cosgrove NM; Swerdel JN; Deng Y; Davis BR; Kostis JB
    Am J Cardiol; 2014 Feb; 113(4):676-81. PubMed ID: 24388619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hypertension and cerebrovascular disease in the elderly.
    Pedelty L; Gorelick PB
    Am J Med; 2008 Aug; 121(8 Suppl):S23-31. PubMed ID: 18638616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should the elderly hypertensive be treated? Evidence from clinical trials.
    Davidson RA; Caranasos GJ
    Arch Intern Med; 1987 Nov; 147(11):1933-7. PubMed ID: 3314763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension in the elderly].
    Plouin PF; Rossignol P; Bobrie G
    Bull Acad Natl Med; 2006; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk management in stroke prevention: major clinical trials in hypertension.
    Borhani NO
    Health Rep; 1994; 6(1):76-86. PubMed ID: 7919093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study on the hypotensive action of a chlorthalidone-reserpine association.
    Strata A; Salvatore V
    Panminerva Med; 1966 Apr; 8(4):113-20. PubMed ID: 5329329
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the anti-hypertensive action of the chlorthalidone-reserpine combination. Clinical contribution].
    Avanzi G
    Minerva Med; 1965 Dec; 56(99):4358-65. PubMed ID: 5323493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.